HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xue-Feng Wu Selected Research

fraxinellone

11/2014Suppression of NF-κB signaling and NLRP3 inflammasome activation in macrophages is responsible for the amelioration of experimental murine colitis by the natural compound fraxinellone.
6/2009Selective triggering of apoptosis of concanavalin A-activated T cells by fraxinellone for the treatment of T-cell-dependent hepatitis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xue-Feng Wu Research Topics

Disease

5Colitis
11/2014 - 09/2005
4Weight Loss (Weight Reduction)
11/2014 - 09/2005
3Hyperalgesia
01/2020 - 11/2011
3Inflammation (Inflammations)
11/2014 - 09/2012
2Pain (Aches)
01/2020 - 01/2018
2Melanoma (Melanoma, Malignant)
09/2015 - 08/2005
2Neoplasms (Cancer)
09/2015 - 02/2013
2Diarrhea
11/2014 - 01/2013
2Mycoses (Diseases, Fungus)
02/2014 - 05/2009
2Crohn Disease (Crohn's Disease)
01/2013 - 01/2010
2Hepatitis
11/2012 - 06/2009
1Neuroinflammatory Diseases
01/2018
1Postoperative Pain
01/2018
1Contact Dermatitis (Eczema, Contact)
03/2013
1Breast Neoplasms (Breast Cancer)
02/2013
1Massive Hepatic Necrosis
11/2012
1Neuralgia (Stump Neuralgia)
11/2011
1Fibrosis (Cirrhosis)
04/2011
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2010
1Neoplasm Metastasis (Metastasis)
08/2005

Drug/Important Bio-Agent (IBA)

4CytokinesIBA
01/2018 - 09/2005
3Sulfonic AcidsIBA
01/2013 - 09/2005
2KATP ChannelsIBA
01/2020 - 11/2011
2fraxinelloneIBA
11/2014 - 06/2009
2Pharmaceutical PreparationsIBA
11/2014 - 01/2013
2Cyclic PeptidesIBA
02/2013 - 01/2013
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2013 - 09/2005
2Concanavalin AIBA
11/2012 - 06/2009
1Opioid Analgesics (Opioids)IBA
01/2020
1Analgesics (Analgesic Drugs)IBA
01/2020
1Morphine (MS Contin)FDA LinkGeneric
01/2020
1Glyburide (Glibenclamide)FDA LinkGeneric
01/2020
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2018
1peoniflorinIBA
01/2018
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2018
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
01/2018
1Toll-Like Receptor 4IBA
01/2018
1TensinsIBA
09/2015
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
09/2015
1InflammasomesIBA
11/2014
1Alkaline PhosphataseIBA
11/2014
1Dextran SulfateIBA
11/2014
1Peroxidase (Myeloperoxidase)IBA
11/2014
1Glutathione (Reduced Glutathione)IBA
11/2014
1ElementsIBA
02/2014
1ChitinasesIBA
02/2014
1vaticaffinolIBA
03/2013
1Picryl Chloride (Trinitrochlorobenzene)IBA
03/2013
1RA VIBA
02/2013
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
02/2013
1InterferonsIBA
01/2013
1sym-trinitrobenzeneIBA
01/2013
1beauvericinIBA
01/2013
1fusarusideIBA
11/2012
1Sulfates (Sulfates, Inorganic)IBA
09/2012
1SodiumIBA
09/2012
1Interleukin-10 (Interleukin 10)IBA
09/2012
1cerebroside DIBA
09/2012
1PotassiumIBA
11/2011
1Adenosine Triphosphate (ATP)IBA
11/2011
1Adenosine Monophosphate (AMP)IBA
11/2011
1Phosphotransferases (Kinase)IBA
11/2011
1Calmodulin (Calcium-Dependent Activator Protein)IBA
11/2011
1Proteins (Proteins, Gene)FDA Link
11/2011
1Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA
11/2011
1Cromakalim (Levcromakalim)IBA
11/2011
1CarbenoxoloneIBA
11/2011
1Ethanol (Ethyl Alcohol)IBA
04/2011
1CollagenIBA
04/2011
1Benzene (Benzole)IBA
01/2010
1cirsilineolIBA
01/2010
1Transaminases (Aminotransferases)IBA
06/2009
1methyl jasmonateIBA
05/2009
1Matrix Metalloproteinases (MMPs)IBA
09/2005
1Interleukin-2 (IL2)IBA
09/2005
1fumigaclavine CIBA
09/2005
1Fibronectins (Fibronectin)IBA
08/2005
1IntegrinsIBA
08/2005

Therapy/Procedure

3Therapeutics
11/2012 - 01/2010